Revenue: The sum of all revenue fields included for a company's operating activities.
Avadel Pharmaceuticals PLC. (AVDL) had Revenue of $68.13M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$68.13M |
$9.66M |
|
$6.37M |
|
$61.76M |
|
$59.24M |
|
$8.88M |
|
$-2.39M |
|
$6.50M |
|
$6.50M |
|
$9.66M |
|
$9.66M |
|
$9.66M |
|
$9.66M |
|
$8.88M |
|
$9.95M |
|
96.73M |
|
99.09M |
|
$0.10 |
|
$0.10 |
|
| Balance Sheet Financials | |
$159.10M |
|
$0.47M |
|
$28.05M |
|
$187.16M |
|
$57.06M |
|
-- |
|
$39.38M |
|
$96.45M |
|
$90.71M |
|
$73.87M |
|
$90.71M |
|
96.78M |
|
| Cash Flow Statement Financials | |
$4.46M |
|
$4.06M |
|
$1.67M |
|
$51.37M |
|
$63.40M |
|
$12.03M |
|
$9.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
90.66% |
|
13.04% |
|
13.04% |
|
-- |
|
9.53% |
|
14.19% |
|
$4.28M |
|
-- |
|
-- |
|
-- |
|
0.36 |
|
0.27 |
|
1.68 |
|
53.67 |
|
10.65% |
|
13.08% |
|
5.16% |
|
10.65% |
|
$0.94 |
|
$0.04 |
|
$0.05 |
|